Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

531
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
531
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

889
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
889
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

944
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
944
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

513
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
513
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

290
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
290
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

216
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
216

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With Metabolic-Dysfunction Associated Steatotic Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Letter: Therapeutic Targeting of PPARs in PBC-Additional Considerations.

Alimentary pharmacology & therapeutics·2026
Same author

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Hepatology communications·2026
Same author

Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis.

Alimentary pharmacology & therapeutics·2026
Same author

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Reply to 'The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view'.

Nature reviews. Gastroenterology & hepatology·2026

関連する実験動画

Updated: Jan 24, 2026

A Fluorescence-based Assay of Phospholipid Scramblase Activity
09:52

A Fluorescence-based Assay of Phospholipid Scramblase Activity

Published on: September 20, 2016

14.6K

低リン脂質関連胆石症候群

Pierre-Antoine Soret1, Olivier Chazouillères1, Christophe Corpechot1

  • 1Service d'hépatologie, centre de référence des maladies inflammatoires des voies biliaires et des hépatites auto-immunes (MIVB-H), centre de référence européen des maladies rares du foie (Rare-Liver), hôpital Saint-Antoine, AP-HP, Paris, France Sorbonne Université, INSERM, centre de recherche Saint-Antoine (CRSA), Paris, France.

La Revue du praticien
|January 23, 2026
PubMed
まとめ

低リン脂質関連胆石症(LPAC)症候群は、まれな遺伝性疾患です。診断には肝臓超音波検査が用いられ、治療には通常、ウルソデオキシコール酸(UDCA)が使用されます。

キーワード:
胆石症

さらに関連する動画

Extraction and Analysis of Microbial Phospholipid Fatty Acids in Soils
10:03

Extraction and Analysis of Microbial Phospholipid Fatty Acids in Soils

Published on: August 26, 2016

32.3K
Fluorescence Recovery after Merging a Droplet to Measure the Two-dimensional Diffusion of a Phospholipid Monolayer
07:54

Fluorescence Recovery after Merging a Droplet to Measure the Two-dimensional Diffusion of a Phospholipid Monolayer

Published on: October 15, 2015

8.4K

関連する実験動画

Last Updated: Jan 24, 2026

A Fluorescence-based Assay of Phospholipid Scramblase Activity
09:52

A Fluorescence-based Assay of Phospholipid Scramblase Activity

Published on: September 20, 2016

14.6K
Extraction and Analysis of Microbial Phospholipid Fatty Acids in Soils
10:03

Extraction and Analysis of Microbial Phospholipid Fatty Acids in Soils

Published on: August 26, 2016

32.3K
Fluorescence Recovery after Merging a Droplet to Measure the Two-dimensional Diffusion of a Phospholipid Monolayer
07:54

Fluorescence Recovery after Merging a Droplet to Measure the Two-dimensional Diffusion of a Phospholipid Monolayer

Published on: October 15, 2015

8.4K

科学分野:

  • 肝臓学
  • 遺伝学
  • 消化器病学

背景:

  • 低リン脂質関連胆石症(LPAC)症候群は、まれな遺伝性疾患です。
  • 症例の30〜50%でMDR3遺伝子の病原性バリアントに関連しています。
  • LPAC症候群は、一般的な胆石症と同様の症状を示しますが、若年成人での発症や手術後の再発が多いのが特徴です。

研究 の 目的:

  • LPAC症候群の特徴を記述すること。
  • LPAC症候群の診断方法と治療選択肢を強調すること。

主な方法:

  • 診断は、肝内微小結石症(彗星尾状の画像または微小斑点)を特定する肝臓超音波検査に依存します。
  • 早期発症や胆嚢摘出後の再発を含む臨床像が、疑いに役立ちます。

主要な成果:

  • 肝内微小結石症の超音波所見は、診断の鍵となる指標です。 若年成人発症(40歳未満)および胆嚢摘出後の再発性胆道症状は示唆的です。

結論:

  • LPAC症候群は、典型的な胆石症を超えた特定の診断アプローチを必要とします。
  • ウルソデオキシコール酸(UDCA)が主要な治療法であり、必要に応じて総胆管結石に対しては内視鏡的処置が行われます。